European Commission
Public Health
Accessibility tools
Service tools
Language selector
- Current languageen
Navigation path
- European Commission
- Public health
- Reference documents
- Register
- Human referrals
- Fortipan Combi D and associated names
Community Register of medicinal products
List of referrals for human medicinal products
Fortipan Combi D and associated names
| Product name: | Fortipan Combi D and associated names |
| Also marketed in the EU under the name(s): | Acrelcombi, Actocalcio D3 |
| INN: | risedronate sodium / calcium carbonate /cholecalciferol |
| Indication: | Treatment of postmenopausal osteoporosis, to reduce the risk of vertebral fractures and the treatment of established postmenopausal osteoporosis, to reduce the risk of hip fractures, |
| Marketing Authorisation Holder: | Not available |
European Commission procedures
| Close date procedure | Procedure type | EMEA number | Decision | summary publ | decision docs | annex |
| 06/10/2010 | Referral | EMEA/H/A-29/1272 | (2010)7032 of 05/10/2010 |